Mangoceuticals Inc (MGRX) Stock Price, Quote & News

Company Profile

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone...

Industry: Health Information Services

Sector: Healthcare

Phone: 214 242 9619

Website: www.mangoceuticals.com

Address:

15110 N. Dallas Parkway, Suite 600, Dallas, United States

SuperGreenToday Apr. 21 at 9:09 PM

$MGRX

0 · Reply

StonkMethod Apr. 21 at 10:13 AM

$MGRX hoping for some good news 📰 soon…

0 · Reply

bundy3333 Apr. 20 at 9:11 PM

$MGRX Do you mean the original author, I responded to? Can't find any hint in the SEC filing, that year's revenue would have tripled within 2025 as falsely stated at this board by the author ... Do you?

0 · Reply

Sam201 Apr. 20 at 7:51 PM

$MGRX he is a stupid paid agent!

2 · Reply

CTL1985 Apr. 20 at 7:42 PM

$MGRX Are we gonna close above $.50? 👀👀

0 · Reply

jirishman Apr. 20 at 7:00 PM

$MGRX told you...this is moving up slowly. I believe there's some new on the horizon about a commercial contract in India for MGX-0024. IMO

0 · Reply

TakingHearts90 Apr. 20 at 5:49 PM

$MGRX $1.17 gap fill.. Historically every gap on the daily has filled up or down.

0 · Reply

jirishman Apr. 20 at 4:50 PM

$MGRX Heading over $.50 and then on to... It's been on the rise for 10 days now.

0 · Reply

SGran Apr. 16 at 11:22 PM

$MGRX never seen the graph steadily up all day with this guy. Something must be coming soon…

0 · Reply

CTL1985 Apr. 16 at 10:19 PM

$MGRX 👀 $GCTS 👀 $GXAI 👀 $COSM 👀

0 · Reply

Mangoceuticals Stock Doubles After Texas Lawsuit

Mar 17, 2026, 4:00 PM EDT - 5 weeks ago

Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.

Mar 6, 2026, 4:00 PM EST - 7 weeks ago

Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds

Feb 23, 2026, 4:05 PM EST - 2 months ago

Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study

Feb 20, 2026, 3:40 PM EST - 2 months ago

Mangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally?

Feb 20, 2026, 9:59 AM EST - 2 months ago

Mangoceuticals Stock Surges On Early Success Of Subscription TRT Model

Feb 19, 2026, 4:05 PM EST - 2 months ago

MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program

Dec 19, 2025, 10:38 AM EST - 4 months ago

Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements

Dec 19, 2025, 7:30 AM EST - 4 months ago

Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy

Dec 18, 2025, 8:30 AM EST - 4 months ago

Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules

Nov 13, 2025, 7:37 PM EST - 5 months ago

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

Nov 13, 2025, 2:04 PM EST - 5 months ago

Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs

LLY NVO

Nov 13, 2025, 7:15 AM EST - 5 months ago

Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs

LLY NVO

May 27, 2025, 9:00 AM EDT - 11 months ago

Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

Apr 28, 2025, 9:36 AM EDT - 1 year ago

ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market

Apr 26, 2025, 10:54 AM EDT - 1 year ago

CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector

Apr 25, 2025, 10:26 AM EDT - 1 year ago

ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector

Apr 25, 2025, 9:00 AM EDT - 1 year ago

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

Apr 22, 2025, 1:55 PM EDT - 1 year ago

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

Feb 3, 2025, 8:30 AM EST - 1 year ago

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation

Dec 19, 2024, 5:33 PM EST - 1 year ago

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

Oct 21, 2024, 5:10 PM EDT - 1 year ago

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

Oct 18, 2024, 8:45 AM EDT - 1 year ago

Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024

Oct 11, 2024, 5:15 PM EDT - 1 year ago

MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN

Oct 3, 2024, 8:30 AM EDT - 1 year ago

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

Oct 1, 2024, 7:30 AM EDT - 1 year ago

MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment

Aug 15, 2024, 9:25 AM EDT - 1 year ago

MangoRx Reports 1,685% Increase in Shareholders' Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024

Aug 9, 2024, 8:15 AM EDT - 1 year ago

MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide

Aug 8, 2024, 8:30 AM EDT - 1 year ago

MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market

Jul 24, 2024, 8:15 AM EDT - 1 year ago

MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology

Jul 18, 2024, 4:05 PM EDT - 1 year ago

Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access

Jul 16, 2024, 8:20 AM EDT - 1 year ago

MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts

Jul 12, 2024, 1:30 PM EDT - 1 year ago

MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department

Jul 11, 2024, 8:15 AM EDT - 1 year ago

MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets

Jun 6, 2024, 8:30 AM EDT - 2 years ago

MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology

Jun 4, 2024, 4:00 PM EDT - 2 years ago

MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies

May 28, 2024, 8:30 AM EDT - 2 years ago

Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets

May 23, 2024, 8:30 AM EDT - 2 years ago

MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts

May 21, 2024, 8:30 AM EDT - 2 years ago

MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications

May 16, 2024, 4:40 PM EDT - 2 years ago

MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration

May 2, 2024, 8:00 AM EDT - 2 years ago

Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

Apr 12, 2024, 8:45 AM EDT - 2 years ago

Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products

Mar 12, 2024, 9:00 AM EDT - 2 years ago

MangoRx Officially Launches ‘PRIME' by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment

Feb 20, 2024, 9:00 AM EST - 2 years ago

MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth

Feb 6, 2024, 9:00 AM EST - 2 years ago

MANGORX TO OFFER THE BIG GAME'S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE

Feb 5, 2024, 8:50 AM EST - 2 years ago

MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product

Jan 19, 2024, 8:00 AM EST - 2 years ago

MangoRx's Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11

Dec 15, 2023, 10:39 AM EST - 2 years ago

Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering

Dec 13, 2023, 7:30 AM EST - 2 years ago

MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT

Dec 6, 2023, 8:00 AM EST - 2 years ago

Mangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin America

SuperGreenToday Apr. 21 at 9:09 PM

$MGRX

0 · Reply

StonkMethod Apr. 21 at 10:13 AM

$MGRX hoping for some good news 📰 soon…

0 · Reply

bundy3333 Apr. 20 at 9:11 PM

0 · Reply

Sam201 Apr. 20 at 7:51 PM

$MGRX he is a stupid paid agent!

2 · Reply

CTL1985 Apr. 20 at 7:42 PM

$MGRX Are we gonna close above $.50? 👀👀

0 · Reply

jirishman Apr. 20 at 7:00 PM

$MGRX told you...this is moving up slowly. I believe there's some new on the horizon about a commercial contract in India for MGX-0024. IMO

0 · Reply

TakingHearts90 Apr. 20 at 5:49 PM

$MGRX $1.17 gap fill.. Historically every gap on the daily has filled up or down.

0 · Reply

jirishman Apr. 20 at 4:50 PM

$MGRX Heading over $.50 and then on to... It's been on the rise for 10 days now.

0 · Reply

SGran Apr. 16 at 11:22 PM

$MGRX never seen the graph steadily up all day with this guy. Something must be coming soon…

0 · Reply

CTL1985 Apr. 16 at 10:19 PM

$MGRX 👀 $GCTS 👀 $GXAI 👀 $COSM 👀

0 · Reply

MajorTom13 Apr. 16 at 7:41 PM

$MGRX very interesting, most of those options might be cleared through? At any rate I don't see much holding this back.

0 · Reply

SGran Apr. 16 at 7:38 PM

$MGRX I sold at .40 yesterday and now 20% up. Best of luck who bought my shares yesterday

0 · Reply

2jmoney Apr. 16 at 7:32 PM

$MGRX slap slap we almost to .50

0 · Reply

jirishman Apr. 16 at 7:17 PM

$MGRX Too many shares being traded and moving up for $MGRX. Something is on the horizon.

0 · Reply

jirishman Apr. 16 at 4:58 PM

$MGRX This has been gradually rising over the last week. Nothing crazy, just steadily up.

0 · Reply

2jmoney Apr. 16 at 3:39 PM

$MGRX cmon now alittle more vol. we need to touch 50 today.

0 · Reply

StockKing8732 Apr. 15 at 4:53 PM

$MGRX pump yo mother

0 · Reply

jirishman Apr. 15 at 4:22 PM

$MGRX if these guys actually produce a PR with good revenue, let's say from the MXG-0024 efforts in India, this is going to run to $1.00. The 10-K indicated they started working not he commercialization efforts in India during the 1st quarter. They have to be close to something in India given the extremely positive test results from their testing.

0 · Reply

Gest1010 Apr. 14 at 3:57 PM

$MGRX Do something, bro

0 · Reply

StonkMethod Apr. 14 at 3:24 PM

$MGRX cooling down

0 · Reply

Kesiya Apr. 14 at 12:19 PM

$EZRA Float: 20.78M EZRA Fee 30.29% Available 150000 Buy zone! next $PMNT $SNAL $SNYR $MGRX

0 · Reply

Turtletrading1 Apr. 13 at 11:29 PM

$MGRX heating up

0 · Reply

Market Cap	7.08M
Revenue (ttm)	460,000.00
Net Income (ttm)	-20.64M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-4,486.96%
Debt to Equity Ratio	0.00

Volume	281,700
Avg Vol	15,465,196
Day's Range	N/A - N/A
Shares Out	16.97M
Stochastic %K	28%
Beta	2.54
Analysts	Strong Buy
Price Target	N/A